Skip to content

Evaluation of a patient-centred biopsychosocial blended collaborative care pathway for the treatment of multi-morbid elderly patients

Evaluation of a patient-centred biopsychosocial blended collaborative care pathway for the treatment of multi-morbid elderly patients - ESCAPE

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00025120
Enrollment
300
Registered
2022-03-31
Start date
2022-04-04
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multimorbidity psychological comorbidity / distress I50

Interventions

Group 1: RCT intervention group: 9 months of routine treatment + support by care manager & feedback on managing psychological distress, heart failure and other comorbidities including access to educat

Sponsors

Univeresitätsmedizin Göttingen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients aged = 65 years 2. Physician-diagnosed chronic heart failure 3. Two or more physician-diagnosed medical comorbidities 4. Elevated psychological distress (HADS total score >12) and/or diagnosed mental disorder(s)

Exclusion criteria

Exclusion criteria: 1. Life expectancy <1 year due to causes other than heart failure 2. Communication barriers (e.g. no telephone, severe hearing impairment, inability to speak, read and understand the language of the country of recruitment) 3. Severe mental disorder needing specific psychiatric treatment and / or interfering with the study treatment, e.g. bipolar disorder, active suicidality, schizophrenia, severe dementia. Current psychosomatic or psychotherapeutic treatment is not an exclusion criterion. 4. Permanently living in a nursing home 5. Being permanently bedridden

Design outcomes

Primary

MeasureTime frame
Health-related quality of life (HRQoL) measured with the EQ-5D-5L at 3 time points: baseline, 9 months and once between 18 - 30 months, depending on time of enrolment

Secondary

MeasureTime frame
Objective medical endpoints: admissions to hospitals and nursing homes, morbidity, all-cause mortality. - Cost-effectiveness & cost-utility - Patient- and carer-reported outcomes: depression and anxiety, disease-specific quality of life, cognitive impairment, frailty, activities of daily living, physical function, physical activity, patient expectations to treatment, sleep problems, pain/ discomfort, treatment burden to patients, informal carer burden, emotional support

Countries

Denmark, Germany, Hungary, Ireland, Italy, Lithuania

Contacts

Public ContactChristine Zelenak

Universitätsmedizin Göttingen, Klinik für Psychosomatische Medizin und Psychotherapie

christine.zelenak@med.uni-goettingen.de+49 (0)551 39-64874

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026